Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 may harm male fertility and damage the reproductive system.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Possible link between COVID-19 and hair loss; more research needed.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Testosterone may influence COVID-19 severity and outcomes.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Melatonin directly affects mouse hair follicles and may influence hair growth.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

New treatments targeting T-cell pathways are needed for better alopecia areata management.